Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Research Field

 Research Field Drug discovery

Unleashing Cellular Potential

| James Strachan

Karin Schmitt, Chief Business Officer at Mogrify, explains how epigenetic switches are being used to identify the optimal culture conditions required to support the conversion and maintenance of any clinically valuable cell type
Research Field Neuroscience

We Need to Talk About Clinical Representation

Alzheimer’s research should benefit all, regardless of ethnicity or race
Research Field Cancer

“Curing Cancer? That’s Cute”

| James Strachan

Cell and gene therapies are now considered mainstream therapeutic modalities – with revolutionary potential. But that hasn’t always been the case…
Research Field Genetics

New Meta-DNA Structures for DNA Origami

A new type of meta-DNA structure promises transformation in the fields of optoelectronics and synthetic biology
Research Field Clinical trials

A Rare Opportunity for Change

| Maryam Mahdi

AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.
Research Field Immunology

Weathering the Cytokine Storm

| Charlotte Barker

THC halts the immune cascade that causes acute respiratory distress syndrome in mice
Research Field Genetics

Gut Feeling

| Phoebe Harkin

Twin study investigates how gut organisms influence the immune system
Research Field Diagnostics & prognostics

Pandemic Proteomics

An MS-based proteomics platform is painting a picture of variable patient responses to COVID-19
Research Field Drug discovery

A Model Experiment

| Audrey Dubourg

Harnessing the potential of microphysiological systems to advance drug discovery.
Research Field Drug discovery

Small, But Mighty

| Brent R Stockwell

Small-molecule inhibition of the SARS-CoV-2 viral protease may represent a promising route for therapy
Research Field Drug discovery

Time to Transform (Re)search and Development

| Claudia Wild

The drug development system is broken; the COVID-19 pandemic is an opportunity to take a bold step towards accessible and affordable therapies
Research Field Neuroscience

A Better AD Model

| Brett Spangler

How primary neuronal cell cultures are unraveling the role of amyloid β oligomers in Alzheimer’s disease.
Research Field Pain & critical care

An Osteoarthritic Odyssey

Sitting Down With… Mike Clayman, CEO of Flexion Therapeutics, Inc., Burlington, Massachusetts, USA.

Latest Solutions

 Research Field Drug discovery

Dental Curing Lights: Clinical Reality

| Contributed by Ocean Optics

Research Field Genetics

Measuring DNA Absorbance with the STS-UV

| Contributed by Ocean Optics

All Solutions

Sister Publications

You might be interested in our Sister Publications:

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register

October Issue of The Translational Scientist